Comparison of the Therapeutic Efficacy and Side Effects of Tramadol Per os (Tradonal Odis Orodispersible Tablets) Versus an Optimised Dosis of Intravenous Tramadol for Postoperative Pain Relief in Ambulatory Surgery.

Trial Profile

Comparison of the Therapeutic Efficacy and Side Effects of Tramadol Per os (Tradonal Odis Orodispersible Tablets) Versus an Optimised Dosis of Intravenous Tramadol for Postoperative Pain Relief in Ambulatory Surgery.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Tramadol (Primary) ; Tramadol
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jan 2013 Planned End Date changed from 1 Jul 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.
    • 16 Jul 2012 Planned end date changed from 1 Aug 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.
    • 16 Aug 2011 Planned end date changed from 1 Dec 2009 to 1 Aug 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top